North America Laboratory Robotics Market Size, Share & Trends Analysis Report By End Use (Clinical Laboratory and Research Laboratory), By Application, By Product, By Country and Growth Forecast, 2024 - 2031

The North America Laboratory Robotics Market is projected to witness market growth of 6.4% CAGR during the forecast period (2024-2031).

The US market dominated the North America Laboratory Robotics Market by Country in 2023, and is forecast to continue being a dominant market till 2031; thereby, achieving a market value of $709.6 million by 2031. The Canada market is experiencing a CAGR of 8.4% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 8.9% during (2024 - 2031).



Laboratory robotics refers to applying robotic systems and automation technology in scientific laboratories to perform various tasks traditionally carried out by humans. These tasks range from simple manual operations to complex, repetitive procedures, often involving precise manipulation of samples, reagents, and laboratory equipment. Laboratory robotics aims to streamline workflows, enhance experimental accuracy, increase throughput, and improve efficiency in scientific research, diagnostics, and industrial applications.

In addition, laboratory robotics find extensive applications across various industries and scientific disciplines, where automation enhances efficiency, accuracy, and throughput. Robotics automate the screening of large compound libraries to identify potential drug candidates. Automated liquid handlers and robotic systems accelerate the process of testing compounds against biological targets, enabling faster drug discovery and development. Robotics automate sample preparation, library construction, and sequencing workflows in genomic research.

Pharmaceutical companies in Canada are increasingly investing in HTS systems powered by laboratory robotics. These systems automate screening large compound libraries, accelerating drug discovery by quickly identifying potential drug candidates with higher precision and efficiency. According to Statistics Canada, in 2020, the R&D pharmaceutical industry contributed $15.9 billion to the Canadian economy in GVA, an increase of 5.8% from the $15.0 billion generated in 2019. Just under half of this ($7.9 billion) was attributable to the direct impacts of the sector, which rose 4.5% from the $7.6 billion generated in 2019. As R&D activities expand in Canada’s pharmaceutical sector, there is a growing demand for laboratory robotics to automate sample handling, processing, and analysis. Robotics enable consistent and reproducible workflows in sample preparation for assays, biomarker analysis, and pharmacological testing, reducing manual errors and enhancing data integrity.

Laboratory robotics facilitate advancements in precision medicine and personalized therapies in Canada’s pharmaceutical industry. Robotics enable handling complex biological samples, genomic testing, and patient-derived models, supporting tailored treatment strategies and improving patient outcomes through targeted therapies.

List of Key Companies Profiled

• Peak Analysis and Automation Ltd (PAA)
• PerkinElmer, Inc.
• Thermo Fisher Scientific Inc.
• Hudson Robotics, Inc.
• Anton Paar GmbH
• Danaher Corporation (Beckman Coulter, Inc.)
• Siemens Healthineers AG (Siemens AG)
• AB Controls, Inc.
• Abbott Laboratories

Market Report Segmentation

By End Use

• Clinical Laboratory
• Research Laboratory

By Application

• Drug Discovery
• Genomics Solutions
• Clinical Diagnosis
• Proteomics Solutions
• Microbiology Solutions

By Product

• Lab Automation Workstations
• Automated Plate Handlers
• Automated Liquid Handling Robots
• Robotic Arms
• Microplate Readers and Washers
• Others

By Country

• US
• Canada
• Mexico
• Rest of North America